Letermovir with an AI-recommendation* in CMV-prophylaxis:
How far can we go from here?

MSD supported Industry Symposium (Hall A)

Saturday, October 26


Chair: Matthias Stelljes, Münster
CMV-prophylaxis with Letermovir: Clinical evidence and benefits
Rafael de la Cámara, Madrid
For recipients of an allogeneic stem cell transplantation 
a CMV-prophylaxis with Letermovir should be considered for...
... selected CMV-seropositive patients
Guido Kobbe, Düsseldorf
... all CMV-seropositive patients
Martin Bornhäuser, Dresden         
Matthias Stelljes, Münster
*according ECIL-7 guidelines